Takara Bio Inc. (FRA:TF2)
Germany
· Delayed Price · Currency is EUR 4.040
-0.120 (-2.88%)
At close: Dec 5, 2025
Takara Bio Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | -4,753 | 1,997 | 2,853 | 21,224 | 27,532 | 13,552 | Upgrade
|
| Depreciation & Amortization | 4,907 | 4,481 | 5,021 | 4,735 | 4,149 | 3,786 | Upgrade
|
| Loss (Gain) From Sale of Assets | 4,258 | 511 | 551 | 97 | 336 | 97 | Upgrade
|
| Other Operating Activities | -891 | -11 | -2,812 | -9,245 | -5,240 | -1,675 | Upgrade
|
| Change in Accounts Receivable | 1 | -2,250 | 1,501 | 5,718 | -4,812 | -3,559 | Upgrade
|
| Change in Inventory | -157 | 102 | -324 | 13,510 | -14,233 | -1,767 | Upgrade
|
| Change in Accounts Payable | 236 | 1,592 | -4,367 | 139 | -431 | 1,016 | Upgrade
|
| Change in Other Net Operating Assets | -812 | -578 | -712 | 719 | -316 | 2,493 | Upgrade
|
| Operating Cash Flow | 2,789 | 5,844 | 1,711 | 36,897 | 6,985 | 13,943 | Upgrade
|
| Operating Cash Flow Growth | -51.27% | 241.56% | -95.36% | 428.23% | -49.90% | 119.96% | Upgrade
|
| Capital Expenditures | -21,134 | -9,871 | -12,778 | -5,747 | -12,403 | -8,687 | Upgrade
|
| Sale of Property, Plant & Equipment | 31 | 5 | 9 | 396 | 47 | 14 | Upgrade
|
| Cash Acquisitions | -6,962 | -546 | - | - | - | - | Upgrade
|
| Investment in Securities | -510 | -94 | 713 | -1,215 | 1,471 | 3,153 | Upgrade
|
| Other Investing Activities | -162 | -406 | -987 | -127 | 3,814 | 1,742 | Upgrade
|
| Investing Cash Flow | -28,737 | -10,912 | -13,043 | -6,693 | -7,071 | -3,778 | Upgrade
|
| Total Debt Issued | 9,951 | - | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 9,951 | - | - | - | - | - | Upgrade
|
| Common Dividends Paid | -2,050 | -2,048 | -5,052 | -3,968 | -1,923 | -962 | Upgrade
|
| Other Financing Activities | -274 | -208 | -181 | -151 | -147 | -141 | Upgrade
|
| Financing Cash Flow | 7,627 | -2,256 | -5,233 | -4,119 | -2,070 | -1,103 | Upgrade
|
| Foreign Exchange Rate Adjustments | -957 | 1,190 | 678 | 813 | 1,008 | -215 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 49 | - | 1 | -1 | - | -2 | Upgrade
|
| Net Cash Flow | -19,229 | -6,134 | -15,886 | 26,897 | -1,148 | 8,845 | Upgrade
|
| Free Cash Flow | -18,345 | -4,027 | -11,067 | 31,150 | -5,418 | 5,256 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | - | 123.09% | Upgrade
|
| Free Cash Flow Margin | -41.62% | -8.94% | -25.44% | 39.86% | -8.00% | 11.40% | Upgrade
|
| Free Cash Flow Per Share | -152.35 | -33.44 | -91.91 | 258.69 | -44.99 | 43.65 | Upgrade
|
| Cash Interest Paid | 19 | 20 | 22 | 24 | 23 | 24 | Upgrade
|
| Cash Income Tax Paid | 1,035 | -86 | 2,359 | 9,902 | 5,922 | 1,854 | Upgrade
|
| Levered Free Cash Flow | -14,539 | -4,825 | -14,752 | 27,578 | -7,401 | 5,743 | Upgrade
|
| Unlevered Free Cash Flow | -14,381 | -4,813 | -14,737 | 27,593 | -7,386 | 5,758 | Upgrade
|
| Change in Working Capital | -732 | -1,134 | -3,902 | 20,086 | -19,792 | -1,817 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.